Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Oracle raises full year profit guidance, stock rises after hours
- Oil surges 6%, Brent and US crude both surpass $100 on more tanker attacks
- Analysts split on Apple after foldable iPhone Duo debut
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Valeant Pharma (VRX) Applies for MCTO with Canadian Securities Regulator AMF
May 17, 2016 6:42 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) provided an update on regulatory matters.
The Company announced that, on May 11, 2016, it applied for a customary management cease trade order ("MCTO") from the Autorité des marchés financiers (the "AMF"), the Company's principal securities regulator in Canada, relating... More
Valeant Pharma (VRX) will hold annual meeting on June 14th - Bloomberg
May 16, 2016 10:29 AM EDTValeant Pharma (NYSE: VRX) will hold annual meeting on June 14th, according to Bloomberg headlines.
... More